Kinetic–pharmacodynamic model of warfarin for prothrombin time–international normalized ratio in Japanese patients
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.15967 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Toshinori Hirai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University, Tsu, Mie, Japan. Hauptthemen laut MEDLINE: Anticoagulants, Warfarin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Aims
Genotype‐guided dosing algorithms can explain about half of the interindividual variability in prothrombin time–international normalized ratio (PT‐INR) under warfarin treatment. This study aimed to refine a published kinetic–pharmacodynamic model and guide warfarin dosage for an optimal PT‐INR based on renal function.
Methods
Using a retrospective cohort of adult patients (>20 years) who were administered warfarin and underwent PT‐INR measurements, we refined the kinetic–pharmacodynamic model with age and the genotypes of cytochrome P450 2C9 and vitamin K epoxide reductase complex subunit 1 using the PRIOR subroutine in the nonlinear‐mixed‐effect modelling programme. We searched the significant covariates for parameters, such as the dose rate for 50% inhibition of coagulation ( EDR 50 ), using a stepwise forward and backward method. Monte Carlo simulation determined a required daily dose of warfarin with a target range of PT‐INR (2.0–3.0 or 1.6–2.6) based on the significant covariates.
Results
A total of 350 patients with 2762 PT‐INR measurements were enrolled (estimated glomerular filtration rate [eGFR]: 47.5 [range: 2.6–199.0] mL/min/1.73 m 2 ). The final kinetic–pharmacodynamic model showed that the EDR 50 changed power functionally with body surface area, serum albumin level and eGFR. Monte Carlo simulation revealed that a lower daily dose of warfarin was required to attain the target PT‐INR range as eGFR decreased.
Conclusions
Model‐informed precision dosing of warfarin is a valuable approach for estimating its dosage in patients with renal impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University, Tsu, Mie, Japan.
- Laboratory of Clinical Pharmacometrics, School of Pharmacy, Nihon University, Funabashi, Chiba, Japan.
- Department of Pharmacy, Tokyo Women's Medical University, Medical Center East, Tokyo, Japan.
ORCID-Profile: Toshinori Hirai
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Hirai, T., Aoyama, T., Tsuji, Y., Itoh, T., Matsumoto, Y., & Iwamoto, T. (2024). Kinetic–pharmacodynamic model of warfarin for prothrombin time–international normalized ratio in Japanese patients. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15967
Vancouver
Hirai T, Aoyama T, Tsuji Y, Itoh T, Matsumoto Y, Iwamoto T. Kinetic–pharmacodynamic model of warfarin for prothrombin time–international normalized ratio in Japanese patients. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15967
BibTeX
@article{Hirai2024,
author = {Hirai, Toshinori and Aoyama, Takahiko and Tsuji, Yasuhiro and Itoh, Toshimasa and Matsumoto, Yoshiaki and Iwamoto, Takuya},
title = {Kinetic–pharmacodynamic model of warfarin for prothrombin time–international normalized ratio in Japanese patients},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.15967}
}
EUVIMED